Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,3',4',5,5',7-hexahydroxyflavone 3-rhamnoside
1. 17912-87-7
2. Myricitroside
3. Myricetrin
4. Myricitrine
5. Myricetin 3-o-rhamnoside
6. Myricetol 3-rhamnoside
7. Myricetin 3-rhamnoside
8. Myricetin 3-o-alpha-l-rhamnopyranoside
9. 5z0zo61wpj
10. Mls000574998
11. Chebi:70082
12. Nsc19803
13. Nsc-19803
14. 5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
15. Smr000232363
16. Myricetin 3-o-alpha-l-rhamnoside
17. 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-benzopyran-4-one
18. 5,7-dihydroxy-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)-4h-chromen-4-one
19. 3,3',4',5,5',7-hexahydroxyflavone, 3-rhamnoside
20. Mfcd00016930
21. 3-[(6-deoxy-alpha-l-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-1-benzopyran-4-one
22. 4h-1-benzopyran-4-one, 3-[(6-deoxy-.alpha.-l-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-
23. 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4h-chromen-3-yl 6-deoxy-alpha-l-mannopyranoside
24. Flavone,3,3',4',5,5',7-hexahydroxy-,3-rhamnoside
25. Unii-5z0zo61wpj
26. Myricitrin (7)
27. 4h-1-benzopyran-4-one, 3-((6-deoxy-.alpha.-l-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-
28. Myricetin 3-o-.alpha.-l-rhamnopyranoside
29. Einecs 241-856-7
30. Nsc 19803
31. Myricetin-3-rhamnoside
32. Myricetin 3- Rhamnoside
33. Myricitrin (myricitrine)
34. Myricitrin [inci]
35. 5,7-dihydroxy-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(3,4,5-trihydroxy-phenyl)-1-benzopyran-4-one
36. Schembl226022
37. Myricitrin, Analytical Standard
38. Chembl522983
39. Megxp0_000257
40. Fema No. 4491
41. Acon1_000103
42. Bdbm34753
43. Cid_5281673
44. Dtxsid40170771
45. Bdbm153266
46. Hms2218n08
47. 5,7-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
48. Hy-n0152
49. Myricitrin, >=99.0% (hplc)
50. Zinc4098556
51. Ac-638
52. Myricetin 3-o-rhamnopyranoside
53. Akos015896842
54. Ccg-208406
55. Ncgc00163596-01
56. Ncgc00163596-02
57. 5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
58. Bs-16289
59. Cs-0007883
60. N1274
61. S2327
62. (3-phenylaminocarbonylphenyl)boronicacid
63. Myricetin 3-o-.alpha.-l-rhamnpyronoside
64. 912m877
65. Sr-01000712005
66. Myricitrin, Primary Pharmaceutical Reference Standard
67. Q6948223
68. Sr-01000712005-3
69. 3-[(2s,3r,4r,5r,6s)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one
70. 3-[(6-deoxy-
71. A-l-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-benzopyran-4-one
72. 5,7-dihydroxy-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-2-(3,4,5-trihydroxyphenyl)-4h-chromen-4-one
73. 5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone
74. 5,7-dihydroxy-3-[[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxy]-2-(3,4,5-trihydroxyphenyl)-1-benzopyran-4-one
| Molecular Weight | 464.4 g/mol |
|---|---|
| Molecular Formula | C21H20O12 |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 3 |
| Exact Mass | 464.09547607 g/mol |
| Monoisotopic Mass | 464.09547607 g/mol |
| Topological Polar Surface Area | 207 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 760 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Myricitrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Myricitrin, including repackagers and relabelers. The FDA regulates Myricitrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Myricitrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Myricitrin supplier is an individual or a company that provides Myricitrin active pharmaceutical ingredient (API) or Myricitrin finished formulations upon request. The Myricitrin suppliers may include Myricitrin API manufacturers, exporters, distributors and traders.
Myricitrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Myricitrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Myricitrin GMP manufacturer or Myricitrin GMP API supplier for your needs.
A Myricitrin CoA (Certificate of Analysis) is a formal document that attests to Myricitrin's compliance with Myricitrin specifications and serves as a tool for batch-level quality control.
Myricitrin CoA mostly includes findings from lab analyses of a specific batch. For each Myricitrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Myricitrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Myricitrin EP), Myricitrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Myricitrin USP).
LOOKING FOR A SUPPLIER?
